Ananya Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-06-2024
- Paid Up Capital ₹ 0.10 M
as on 28-06-2024
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -39.01%
(FY 2015)
- Profit -514.12%
(FY 2015)
- Ebitda -2270.79%
(FY 2015)
- Net Worth -16.93%
(FY 2015)
- Total Assets -16.39%
(FY 2015)
About Ananya Lifescience
The Corporate was formerly known as Ananya Lifesciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Geeta Lulla, Shonaal Lulla, and Shailesh Patel serve as directors at the Company.
- CIN/LLPIN
U24100MH2004PTC144020
- Company No.
144020
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2004
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ananya Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Lulla  | Director | 16-Jan-2004 | Current |
| Shonaal Lulla | Director | 16-Jan-2004 | Current |
| Shailesh Patel | Director | 29-Aug-2018 | Current |
Financial Performance of Ananya Lifescience.
Ananya Lifescience Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 39.01% decrease. The company also saw a substantial fall in profitability, with a 514.12% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ananya Lifescience?
In 2017, Ananya Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
L'amar Natural Product Private LimitedActive 29 years 6 monthsGeeta Lulla, Shonaal Lulla and 1 more are mutual person
Amar-Deep Pharmas LlpActive 13 years 7 monthsGeeta Lulla, Shonaal Lulla and 1 more are mutual person
- Renaissance Lifesciences India LlpActive 13 years 5 months
Geeta Lulla, Shonaal Lulla and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ananya Lifescience?
Unlock and access historical data on people associated with Ananya Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ananya Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ananya Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
